Wolverine Asset Management LLC Ptc Therapeutics, Inc. Put Options Transaction History

Wolverine Asset Management LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 04, 2024	SELL	$30.39 - $37.66 $167,145 - $207,129	-5,500 Reduced 58.51%	3,900 $144,000
Q2 2024 Aug 01, 2024	SELL	$24.69 - $40.12 $540,711 - $878,628	-21,900 Reduced 69.97%	9,400 $287,000
Q1 2024 May 13, 2024	SELL	$24.15 - $31.95 $113,505 - $150,165	-4,700 Reduced 13.06%	31,300 $910,000
Q4 2023 Feb 01, 2024	BUY	$18.07 - $29.37 $337,909 - $549,219	18,700 Added 108.09%	36,000 $992,000
Q3 2023 Nov 13, 2023	BUY	$22.41 - $41.99 $387,693 - $726,427	17,300 New	17,300 $387,000
Q3 2022 Nov 10, 2022	BUY	$41.85 - $53.85 $276,210 - $355,410	6,600 New	6,600 $331,000
Q1 2019 May 15, 2019	SELL	$28.09 - $39.49 $356,743 - $501,523	-12,700 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$25.7 - $47.88 $69,390 - $129,276	2,700 Added 27.0%	12,700 $428,000
Q1 2018 May 15, 2018	SELL	$17.46 - $32.59 $345,708 - $645,282	-19,800 Reduced 66.44%	10,000 $270,000
Q4 2017 Feb 14, 2018	BUY	$15.14 - $20.89 $451,172 - $622,522	29,800	29,800 $497,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.28B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.